首页 | 本学科首页   官方微博 | 高级检索  
     

点刺放血治疗慢性疲劳综合征32例疗效观察
引用本文:廖辉. 点刺放血治疗慢性疲劳综合征32例疗效观察[J]. 中国针灸, 2004, 24(2): 91-92
作者姓名:廖辉
作者单位:营口市中医院,辽宁,115000
摘    要:
目的:观察放血疗法治疗慢性疲劳综合征的疗效及其对体液免疫、细胞免疫的影响.方法:点刺太阳、心俞、肺俞、大椎、足三里,加拔火罐10 min,同时测定治疗前后IgG、IgA、IgM、C3、C4的含量和CD3 、CD4 、CD8 的含量.结果:显效15例,占46.9%;有效12例,占37.5%;总有效率为84.4%.放血治疗后C3、C4含量较治疗前下降(P<0.05).同时CD4 水平下降,CD8 水平升高,CD4 /CD8 比值下降,与治疗前比差异有显著和非常显著性意义(P<0.05,P<0.01).结论:点刺放血治疗慢性疲劳综合征可以改善临床症状,消除体征;并提示放血治疗对异常的补体有纠正作用,对细胞免疫系统有调节作用.

关 键 词:刺血疗法  拔罐  疲劳综合征,慢性/针灸疗法
文章编号:0255-2930(2004)02-0091-02
修稿时间:2003-03-26

Observation on therapeutic effect of pricking blood therapy in 32 cases of chronic fatigue syndrome
LIAO Hui. Observation on therapeutic effect of pricking blood therapy in 32 cases of chronic fatigue syndrome[J]. Chinese acupuncture & moxibustion, 2004, 24(2): 91-92
Authors:LIAO Hui
Abstract:
ObjectiveTo observe therapeutic effect of pricking b lood therapy on chronic fatigue syndrome (CFS) and effects on humoral immunity a nd cellular immunity. MethodsPricking blood therapy was given at Taiyang(EX-HN5), Xinshu(BL 15), Feishu(BL 13), Dazhui(GV 14), Zusanli(ST 36) , and cupping was added for 10 min. IgG, IgA, IgM, C 3, C 4 and CD 3 ,CD 4 , CD 8 contents were determined before and after treatment. Resu lts15 cases were markedly effective, accounting for 46 95%; 12 cases were effective, accounting for 37 5%, with a total effective rate of 84 4%. Af ter treatment, C 3 and C 4 contents decreased (P<0 05), and CD 4 leve l reduced and CD 8 level increased, CD 4 /CD 8 ratio decreased, wit h significant differences as compared with the data before treatment (P<0 05, or P<0 01). ConclusionPricking blood therapy can im prove clinical symptoms and eliminate physical signs, and correct abnormal compl ements and regulate the cellular immunity system in the patient of chronic fatig ue syndrome.
Keywords:Pricking Blood Therapy  Cupping Therapy  Fatigue Syndrome    Chronic/acup-mox ther
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国针灸》浏览原始摘要信息
点击此处可从《中国针灸》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号